ZTS — Zoetis

Pharmaceuticals · Health Care

Key Facts

StatusActive
SectorHealth Care
IndustryPharmaceuticals
Joined2013-06-21
Tenure13 yrs
Zoetis Inc. is engaged in the discovery, development, manufacture and commercialization of drugs, vaccines, diagnostic products and services, biological devices, genetic tests and precision animal health technologies. The company operates through U.S. and International geographic segments. The U.S. segment participates in U.S. markets and regulatory activities. The International segment includes non-U.S. markets and regulatory activities.

Industry Peers

Sector Peers

S&P 500 Timeline

2013-06-21Joined S&P 500

Institutional Holdings (13F)

1,610 institutions hold ZTS, totaling 539.0M shares ($65.7B) · As of 2026Q1

RankInstitutionSharesValue
1VANGUARD CAPITAL MANAGEMENT LLC52.1M$6.2B
2MORGAN STANLEY46.6M$6.1B
3DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main29.6M$4.9B
4BlackRock, Inc.35.6M$4.2B
5VANGUARD PORTFOLIO MANAGEMENT LLC24.0M$2.8B
6BARCLAYS PLC16.4M$2.7B
7STATE STREET CORP19.3M$2.3B
8STATE FARM MUTUAL AUTOMOBILE INSURANCE CO15.9M$1.9B
9Employees Provident Fund Board10.9M$1.7B
10GEODE CAPITAL MANAGEMENT, LLC11.3M$1.3B

View all holders →

Data source: Wikipedia · CC BY-SA 4.0 · SEC EDGAR 13F · Updated 2026-07-10